Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology

Leukemia and Lymphoma

Volumn 47, Issue 9, 2006, Pages 1774-1781

  Gianelli, Umberto ^a   Vener, Claudia ^a   Raviele, Paola Rafaniello ^a   Moro, Alessia ^a   Savi, Federica ^a   Annaloro, Claudio ^a   Somalvico, Francesco ^a   Radaelli, Franca ^b   Franco, Vito ^c   Deliliers, Giorgio Lambertenghi ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Bone marrow histology; Chronic myeloproliferative disorders

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE MARROW BIOPSY; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ERYTHROPOIESIS; FEMALE; FOLLOW UP; GRANULOCYTE; GRANULOPOIESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PATHOLOGICAL ANATOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTHEMIA;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; BONE MARROW EXAMINATION; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; POLYCYTHEMIA VERA; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 33750477331     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600678975     Document Type: Article

References (24)

1. Murphy, S and Iland, H and Rosenthal, D and Laszlo, J. (1986) Essential thrombocythaemia: An interim report from the Polycythaemia Vera Study Group Semin Hematol, 23, pp. 177-182.
2. Murphy, S and Peterson, P and Iland, H and Laszlo, J. (1997) Experience of the Polycythaemia Vera Study group with essential thrombocythaemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment Semin Hematol, 34, pp. 29-39.
3. Tefferi, A and Murphy, S. (2001) Current opinion in essential thrombocythaemia: Pathogenesis, diagnosis, and management Blood Rev, 15, pp. 121-131.
4. Thiele, J and Schneider, G and Hoeppner, B and Wienhold, S and Zankovich, R and Fischer, R. (1988) Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis-features of significance for the diagnosis of primary (essential) thrombocythaemia Virchows Arch A Pathol Anat Histopathol, 413, pp. 407-417.
5. Georgii, A and Vykoupil, K and Buhr, T and Choritz, H and Dohler, U and Kaloutsi, V and (1990) Chronic myeloproliferative disorders in bone marrow biopsies Pathol Res Pract, 186, pp. 3-27.
6. Georgii, A and Buhr, T and Buesche, G and Kreft, A and Choritz, H. (1996) Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies Leuk Lymphoma, 22(Suppl 1), pp. 15-29.
7. Thiele, J and Kvasnicka, H and Zankovich, R and Diehl, V. (2000) Relevance of bone marrow features in the differential diagnosis between essential thrombocythaemia and early stage idiopathic myelofibrosis Haematologica, 85, pp. 1126-1134.
8. Michiels, J and Thiele, J. (2002) Clinical and pathological criteria for the diagnosis of essential thrombocythaemia, polycythaemia vera, and idiophatic myelofibrosis (angiogenic myeloid metaplasia) Int J Hematol, 76, pp. 133-145.
9. Annaloro, C and Lambertenghi Deliliers, G and Oriani, A and Pozzoli, E and Lambertenghi Deliliers, D and Radaelli, F and (1999) Prognostic significance of bone marrow biopsy in essential thrombocythaemia Haematologica, 84, pp. 17-21.
10. Vardiman, J and Brunning, R and Harris, N.(2001) Chronic myeloproliferative diseases. In WHO Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues. (pp. 39-41). Lyon: IARC Press.
11. Thiele, J and Kvasnicka, H and Boeltken, B and Zankovich, R and Diehl, V and Fischer, R. (1999) Initial (prefibrotic) stages of idiopathic (primary) myelofybrosis (IMF). A clinicopathological study Leukemia, 13, pp. 1741-1748.
12. Thiele, J and Kvasnicka, H and Schmitt-Graeff, A and Zankovich, R and Diehl, V. (2002) Follow-up examinations including sequential bone marrow biopsies in essential thrombocythaemia (ET): A retrospective clinicopathological study of 120 patients Am J Hematol, 70, pp. 283-291.
13. Thiele, J and Kvasnicka, H. (2003) Chronic myeloproliferative disorders with thrombocythaemia: A comparative study of two classification systems (PVSG, WHO) on 839 patients Ann Hematol, 82, pp. 148-152.
14. Florena, A and Tripodo, C and Iannitto, E and Porcasi, R and Ingrao, S and Franco, V. (2004) Value of bone marrow biopsy in the diagnosis of essential thrombocythaemia Haematologica, 89, pp. 911-919.
15. Kreft, A and Buche, G and Ghalibafian, M and Buhr, T and Fischer, T and Kirkpatrick, C. (2005) The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopatic myelofibrosis: A retrospective evaluation of sequential bone marrow biopsies Acta Haematol, 113, pp. 137-143.
16. Thiele, J and Kvasnicka, H and Facchetti, F and Franco, V and Van der Walt, J and Orazi, A. (2005) European consensus for grading of bone marrow fibrosis and assessment of cellularity Haematologica, 98, pp. 1128-1132.
17. Thiele, J and Kvasnicka, H. (2003) Diagnostic differentiation of essential thrombocythaemia from thrombocythaemias associated with chronic idiopathic myelofibrosis by discriminate analysis of bone marrow features - a clinicopathological study on 272 patients Histol Histopathol, 18, pp. 93-102.
18. Barbui, T and Barosi, G and Grossi, A and Gugliotta, L and Liberato, L and Marchetti, M and (2004) Practice guidelines for the therapy of essential thrombocythaemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation Haematologica, 89, pp. 215-232.
19. Cortes, J and Ault, P and Koller, C and Thomas, D and Ferrajoli, A and Wierda, W and (2003) Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome Blood, 101, pp. 4714-4716.
20. Marchetti, M and Barosi, G and Balestri, F and Viarengo, G and Gentili, S and Barulli, S and (2004) Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial J Clin Oncol, 22, pp. 424-431.
21. Faoro, L and Tefferi, A and Mesa, R. (2005) Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia Eur J Haematol, 74, pp. 117-120.
22. Barosi, G and Ambrosetti, A and Finelli, C and Grossi, A and Leoni, P and Liberato, N and (1999) The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia Br J Haematol, 104, pp. 730-737.
23. Thiele, J and Kvasnicka, H and Diehl, V. (2005) Initial (latent) polycythaemia vera with thrombocytosis mimicking essential thrombocythaemia Acta Haematol, 113, pp. 213-219.
24. Thiele, J and Kvasnicka, H and Diehl, V. (2005) Standardization of bone marrow features - does it work in hematopathology for histological discrimination of different disease patterns? Histol Histopathol, 20, pp. 633-644.